Carpentier, Alain

(redirected from Alain Carpentier)
Also found in: Wikipedia.

Carpentier,

Alain, 20th century French cardiothoracic surgeon.
Carpentier annuloplasty
Carpentier annuloplasty ring prosthesis
Carpentier-Edwards aortic valve prosthesis
Carpentier-Edwards bioprosthesis
Carpentier-Edwards bioprosthetic valve
Carpentier-Edwards mitral annuloplasty valve
Carpentier-Edwards pericardial valve
Carpentier-Edwards porcine prosthetic valve
Carpentier-Edwards valve
Carpentier ring
Carpentier stent
Carpentier tricuspid valvuloplasty
Carpentier valve
References in periodicals archive ?
A March 16, 2014 article by the Reuters news service said, "The device's inventor, French surgeon Alain Carpentier, told the weekly Journal du Dimanche.
The artificial heart was developed by a team of engineers from EADS company and the inventor of heart valves, Alain Carpentier.
Surgeon Alain Carpentier said: "It's about giving patients a normal social life.
Heart specialist Alain Carpentier said it had taken him 15 years to perfect.
Its inventor, top French heart surgeon Alain Carpentier, said: "If you show the graphs to a cardiac surgeon, he will say it is a human heart.
Alain Carpentier of Paris, France and Albert Starr of Portland, OR were winners of the Albert Lasker Award in clinical research.
Last month Paris surgeon Alain Carpentier carried out the world's first human open heart operations using a remote-controlled robot.
When surgeons Alain Carpentier and Juan Carlos Chachques of the University of Paris's Hopital Broussais removed the 14-kilogram tumor, they reinforced the thin muscle wall that remained with a "borrowed' muscle from her lower back, the left latissimus dorsi.
Substantial involvement of prestigious founders and shareholders: Truffle Capital, the leading European venture capital firm, EADS, the Foundation Alain Carpentier (Carmat's co-founder) and thousands of institutional and individual shareholders who have also shown their confidence in CARMAT.
Alain Carpentier, chairman of the Department of Cardiovascular Surgery at the Hopital Europeen Georges Pompidou in Paris.
Carpentier-Edwards biological heart valves were developed by CARMAT co-founder and CSO Professor Alain Carpentier and will be, for the very first time, used in an artificial heart.
Paris-based CARMAT was incorporated in June 2008 and financed by TRUFFLE CAPITAL, EADS and the Fondation Alain Carpentier, with additional funding from the French state innovation agency OSEO.